Blog - Page 244 of 5679 - QualityStocks

TuesdaySep 16, 2025 10:41 am

QualityStocksNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Spotlighted in NetworkNewsWire Editorial on AI-Powered Wearables

Wearable Devices (NASDAQ: WLDS) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “AI-Powered Wearables Transform How Consumers Interact with Everyday Technology” (https://nnw.fm/AYAOv). The article highlights growing global demand for neural interface technologies as consumers and industries seek seamless, gesture-based control beyond touchscreens and voice assistants. Positioned at the forefront of this trend, Wearable Devices has introduced its AI-powered Mudra Band for Apple Watch and the Mudra Link platform, offering intuitive, touchless interaction across ecosystems. To view the full press release, visit https://ibn.fm/KkOCg About Wearable Devices Ltd. Wearable Devices Ltd. is a growth company pioneering human-computer interaction through its AI-powered neural…

TuesdaySep 16, 2025 10:30 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Completes Phase 1a Trial of LP-184 With Favorable Safety, PK Profile and Early Antitumor Activity

Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology company, announced the successful completion of its Phase 1a clinical trial for LP-184 (NCT05933265), which met all primary endpoints, showing a favorable safety and pharmacokinetic profile with early signs of antitumor activity. The open-label study in 63 patients with advanced relapsed or refractory solid tumors, including GBM, demonstrated disease control in 48% of evaluable patients at therapeutic dose levels, with notable responses in DDR-deficient cancers such as NSCLC, colon cancer, thymic carcinoma, and GIST. No dose-limiting toxicities were observed, and adverse events were predominantly mild. Lantern plans to advance LP-184 into Phase 1b…

TuesdaySep 16, 2025 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces First-Ever Qubits Japan 2025 Quantum Computing User Conference

D-Wave is hosting a quantum computing user conference called Qubits Japan 2025 in Tokyo on September 17, 2025. The event is themed “Quantum Realized” and will feature presentations highlighting customer success stories, technical roadmap updates, scientific achievements and advancements in quantum AI. This follows an 83% increase in bookings for D-Wave’s annealing quantum computing technology in the Asia Pacific region as organizations develop optimization and quantum AI applications D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or “The Company”), a leader in quantum computing systems, software, and services, recently announced that it is hosting its first-ever Qubits Japan 2025 quantum computing user…

TuesdaySep 16, 2025 10:10 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) to Launch Electric UTV in 2026, Expanding Portfolio in Growing Market

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles, announced plans to debut its first electric utility terrain vehicle (UTV) in 2026, marking its entry into the fast-growing electric utility vehicle market. Powered by a 72V 200AH lithium battery and a 15KW permanent magnet synchronous motor, the new UTV delivers up to 70 kilometers per charge, real-time 4WD, a top speed of 45 km/h, and a 7-inch (optional 10-inch) touchscreen display. CEO David Shan said the model addresses rising demand among environmentally conscious consumers and agricultural users, while positioning Massimo for significant growth opportunities. To view the full press…

TuesdaySep 16, 2025 10:02 am

QualityStocksNewsBreaks – OptimumBank Holdings, Inc. (NYSE American: OPHC) Engages IBN to Lead Corporate Communications Strategy

OptimumBank Holdings (NYSE American: OPHC), the parent of OptimumBank, a Fort Lauderdale-based community bank with more than $1 billion in assets, has selected IBN to spearhead its corporate communications efforts. OptimumBank, specializing in real estate and commercial lending, ranks among the region’s fastest-growing and most profitable community banks, with return on equity well above industry averages. The bank, which achieved SBA Preferred Lender status in just over two years, continues to scale efficiently while focusing on technology modernization and maintaining its relationship-based banking model. To view the full press release, visit https://ibn.fm/FtnYz About OptimumBank Holdings Inc. OptimumBank was founded in 2000…

TuesdaySep 16, 2025 9:50 am

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches FAQ Page to Enhance Transparency and Investor Engagement

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging-based products for the detection and treatment of breast cancer, has launched a new Frequently Asked Questions page on its corporate website at www.izocorp.com/faq. The resource provides accessible information on the company’s IzoView Breast CT Imaging System, development milestones, and competitive positioning, addressing topics such as breast density, imaging workflow, and comparisons with other modalities. Optimized for search and AI platforms, the FAQ page supports Izotropic’s investor relations, clinical outreach, and advocacy initiatives. To view the full press release, visit https://ibn.fm/I1kkE About Izotropic More information about Izotropic Corporation…

TuesdaySep 16, 2025 9:45 am

Clene Inc.’s (NASDAQ: CLNN) Lead Candidate CNM-Au8(R) Shows Promise in Improving Cellular Health in Parkinson’s Disease

Clene Inc. reported new preclinical data on its drug candidate CNM-Au8 for Parkinson’s disease. The therapy improved mitochondrial health, restored cellular metabolism, reduced inflammation, and normalized gene expression in dopaminergic neurons. Findings were presented at the Michael J. Fox Foundation’s H2 Therapeutics Stewardship Meeting in New York City. CNM-Au8 previously showed positive energetic and metabolic effects in a Phase 2 Parkinson’s trial, aligning with the new preclinical results. The treatment demonstrated no toxicity in neuronal models, consistent with safety data from over 1,000 patient-years in ALS and MS trials. Clene plans to design a Phase 2 clinical study for Parkinson’s…

TuesdaySep 16, 2025 9:42 am

QualityStocksNewsBreaks – FAVO Capital (OTC: FAVO) Appoints Zachary Graeve as Independent Director and Governance Chair

FAVO Capital (OTC: FAVO), a diversified financial company with operations in financial services and real estate, has appointed Zachary Graeve to its board of directors as an independent director and chair of the Nominating and Corporate Governance Committee. Graeve, an IRC-credentialed governance advisor with more than 20 years of experience in investor relations and board advisory, has guided executive teams through IPOs, acquisitions, and market transitions. His appointment strengthens FAVO’s governance and capital markets strategy as the company advances plans for an uplisting to a national exchange. To view the full press release, visit https://ibn.fm/Svk8s About FAVO Capital, Inc. FAVO Capital, Inc.…

TuesdaySep 16, 2025 9:30 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsWire Editorial Highlighting Innovative Therapeutics Pipeline

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth” (https://ibn.fm/WpGOO). The piece spotlights Oncotelic’s leadership in RNA-based, immunotherapy, and targeted therapeutics, addressing critical unmet needs in aggressive cancers and pediatric rare diseases. Led by chair and CEO Dr. Vuong Trieu, the company is advancing a portfolio supported by more than 500 patent applications and 75 issued patents, leveraging AI, nanomedicine, and novel clinical models to transform cancer and rare disease treatment. To view the full press release, visit https://ibn.fm/Wtn6b About Oncotelic Therapeutics Inc. Oncotelic Therapeutics is a…

TuesdaySep 16, 2025 9:23 am

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) to Present at ArcStone-Kingswood Growth Summit 2025 in Toronto

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company delivering performance-driven innovations through physics-based engineering, announced its management team will present at the ArcStone-Kingswood Growth Summit 2025 on Sept. 18 at The St. Regis Toronto. Chairman and CEO Greg Campbell and CFO Jeff Clayborne will highlight Newton’s strong year-to-date financial results, accelerating adoption of its Motion and Fast Motion shafts on Tour, and long-term growth outlook during the Digital Transformation & Frontier Tech track. To view the full press release, visit https://ibn.fm/Q0ip0 About Newton Golf Company Newton Golf Company (NASDAQ: NWTG) is a pioneering golf technology company redefining performance through…

Site Search

Company Search